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INTRODUCTION
Shaker K+ channels modified by point mutation were
expressed in Xenopus oocytes and their block by recom-
binant charybdotoxin (crX), a peptide inhibitor of K+
channels, was studied. In particular, the effect of modify-
ing residues in the pore-associated S5-S6 "linker" re-
gion of the channel was assessed. We found that
changing just one Shaker residue from phenylalanine to
glycine increased the affinity of the channel's crx-
receptor over 1,900-fold. Kinetic analysis revealed that
the increase in binding affinity is due wholly to a
decrease in toxin dissociation rate. This result demon-
strates that a crx receptor exists in the Shaker channel
mouth, but that the presence of a phenylalanine in this
position destabilizes the toxin on the binding site.
METHODS AND MATERIALS
Biochemical methods
The inactivation-removed Shaker channel variant used in this work was
kindly provided by R. MacKinnon and was produced by deletion of
amino acids 6-46 from Shaker H4 while in BluescriptKS+ (Strata-
gene). Site-directed mutagenesis was performed by the method of
Kunkel (1). Mutations were confirmed by dideoxy sequencing and
cRNA was prepared using T7 RNA polymerase (Promega) supple-
mented with capping nucleotide as previously described (2). Recombi-
nant crx was purified in fully active form after cleavage from a fusion
protein produced in E. coli, as previously described (3).
Electrophysiology
Xenopus oocytes (NASCO) were prepared and injected with cRNA as
previously described (2). Currents were recorded from outside-out
macropatches without leak subtraction (Axopatch-1C, Axon Instru-
ments, CA). The bath solution contained 100 mM NaC!, 2 mM KCI, 1
mM MgCI2, 1.8 mM CaC!2' and 10 mM Hepes (pH 7.1). Toxin was
added to the bath solution with 25 p,g/ml albumin. The pipette
solution was 100 mM KCl, 1 mM MgCI2, 5 mM EGTA, and 10 mM
Hepes (pH 7.1). All experiments were performed at 21-23°C with the
oocyte membrane potential held at -100 mV. During toxin perfusion
and wash-out, currents were measured by periodic depolarizing pulses
until equilibrium was reached. Calculations were made only from
patches which persisted through both blocking and wash-out of toxin.
RESULTS AND DISCUSSION
Charybdotoxin (crX) is a 37-residue peptide derived
from scorpion venom which inhibits a variety of K+
channels at nanomolar concentrations (3). Mechanistic
studies on Caz+-activated K+ channels have shown that
one crx molecule binds to a receptor site located in the
channel's externally facing "mouth" and physically oc-
cludes its conduction pathway (4, 5). We are working to
develop a picture of the crx receptor of voltage-gated
K+ channels using recombinant crx as a molecular
probe.
crx blocks Shaker K+ channels with far lower affinity
(I<, ,.., 200 nM) than it blocks the mammalian Shaker
homologue Kv3 (I<,"" 0.1 nM) when studied using
two-electrode voltage clamp ofXenopus oocytes express-
ing the channels (6; Goldstein, S. A. N. and C. Miller,
unpublished data). Because the scorpion toxin receptor
of Shaker-type K+ channels appears to formed by resi-
dues in the pore-associated S5-S6 linker region (7), we
compared the corresponding sequences of the two
channels. Shaker differs from Kv3 in 10 of the 22 amino
acid residues comprising the toxin receptor domain,
Fig. 1. To assess if these differences influenced the
toxin-receptor interaction, we probed the sites via mu-
tagenesis.
In these studies we used a Shaker variant modified by
an NHz-terminal deletion which removes fast inactiva-
tion but does not alter toxin inhibition (8). Point
mutations in the crX-receptor region of Shaker did not
alter the gating kinetics, K+-selectivity, nor the expres-
sion level of these channels in Xenopus oocytes (data not
shown). K+ currents of 500 to 2,000 pA were typical in
outside-out excised macropatches used for blocking
studies, Fig.2A. When the phenylalanine residue at
position 425 in the Shaker S5-S6 linker sequence was
mutated to glycine (found at the equivalent position in
Kv3) the affinity of the Shaker crX-receptor increased
nearly 2,000-fold, Fig. 2 B.
The kinetics of CTX binding and dissociation were
studied by using outside-out macropatches in a rapid
perfusion system (8) modified to exchange the bath
solution with a rise time of 10 ms. The rate constants
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FIGURE 3 crx blocking kinetics of Shaker/425G. (A) Currents were
elicited by 15 ms depolarizing pulses to -20 mV from a holding
potential of -loo mV every 5 s until equilibrium blockade was
reached. After four control pulses the patch was exposed to 0.5 nM
crx. The scale bars represent 0.2 nA and 2 ms. (B) The raw
macroscopic current is plotted as a function of time after solution
change, t. The curve was fit according to I(t) = I~ + (/0 - I~)e(-l/T); 'I" =
30.3 s.
Because the structure of crx is known (9), we hope
to use this molecule as a caliper to measure physical
distances between residues making up its receptor site in
the Shaker channel mouth, a functionally important
region of the outer conduction pathway (10). Both crx
and its binding site can be altered through site-directed
mutation and we will seek complementary point muta-
tions to map their interaction. Shaker position 425
appears to be a strong candidate for a local channel
contact point with a specific toxin residue, in part,
because isoforms of crx with only a few amino acid
differences tolerate a phenylalanine in position 425 and
block Shaker with high affinity (8).
TABLE 1 Kinetic parameters for CTX block of Shaker K+
channels
crx blockade of Shaker/425G was performed as described in Fig. 3.
Blockade ofShaker/425F was evaluated by curve fitting raw data over a
single 3oo ms test sweep (data not shown). The equilibrium dissocia-
tion and rate constants are given in terms of the measured time
constant, '1", and the fraction of unblocked current,!uo; I<, = [CTX]/un/
(1-/un)' koff = lunl-r and kon = (1-/un)/'I"[crx]. As expected for a
bimolecular reaction, the on-rate for binding of CTX was found to be
linearly dependent on toxin concentration, whereas the off-rate was
independent of toxin concentration and was used as a confirmation of
the value calculated from CTX wash-in data (data not shown).
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were determined from the time-course of the transition
from unblocked to equilibrium-blocked current levels.
Fig. 3 shows the progressive block of K+ currents through
Shaker/425G channels in a patch abruptly exposed to 0.5
nM crx, and a plot of the unblocked current as a
function of time from which K j , kOD' and koff were
determined.
Kinetic analysis revealed that the large change in the
affinity ofthe crX-receptor interaction was the result of
an effect on toxin off-rate, Table 1. Mutation of Shaker
position 425 from phenylalanine to glycine leaves the
on-rate unchanged, whereas toxin off-rate was de-
creased over 1,800-fold. This result demonstrates that a
crx receptor structure exists in the Shaker channel
mouth, but that a phenylalanine at position 425 destabi-
lizes crx in the site by -4.5 kcallmol.
FIGURE 1 Partial amino acid sequence of the S5-S6 linker region of
Shaker and Kv3. Residues comprising the toxin receptor domains are
displayed, the asterisk (*) indicates Shaker position 425 (11) which is
equivalent to Kv3 position 377 (12). The channels are homologous
through the 17 amino acid stretch thought to comprise the channel
deep pore region, H5 (10).
FIGURE 2 crx blockade of Shaker/425F and Shaker/425G. (A) K+
currents were measured in outside-out excised macropatches from
Xenopus oocytes. The membrane potential was held at -loo mV and
depolarized for 10 ms to test potentials from -40 to +40 in 20 mV
increments. The scale bars represent 0.2 nA and 2 ms. (B) The fraction
of unblocked current (//10) is plotted as a function of crx concentra-
tion. Currents were measured during 10 ms test pulses to - 20 or 0 mV
from a holding potential of -loo mV once equilibrium blockade was
achieved. Each point is the mean ± SEM for three or more determina-
tions. The solid curves are fit to I110 = (1 + [crx]/IQ-'. Equilibrium
dissociation constants (I<,) are reported in Table 1.
~ * ~ ~Shaker ",·,,·,·'E A G SEN S F F K SIP 0 ",·",,1 T P V G V W G K ,·,·,··,,··,,1
Kv3 f·,·,·,··,··,EA OOPS SGF N SIP D,·,··,,··'H PV T I G G K ..····I
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Note added in proof Mutation of Shaker position 425 from F to G, as
described in this report, was recently also reported to increase crx
binding affinity in wild-type, inactivating Shaker H4 by Oliva, c., R.
Wiedmann, C. Bennett, K. Folander, R. Swanson, and J. Smith
(1991). Mutations in the S5-S6 of Kv3 affect charybdotoxin blockade
and the rate ofslow inactivation (Soc. Neurosci. 17:775a. (Abstr.)).
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